Aesthetic Lasers

Lasers offer | Laser offers

Aerolase LightPod® Lasers

LightPod Neo™ with MicroPulse-1064™
  • pain-free laser hair removal on all skin types
  • Pseudofolliculitis Barbae (PFB or ingrown hair)
  • spider veins and rosacea; angiomas and other vascular conditions
  • pigmented lesions and age spots
  • photorejuvenation with skin tightening
  • psoriasis
  • skin and nail fungus laser treatment

LightPod Neo case LightPod Neo front view LightPod Neo top view

Aerolase represents a new era in compact, cost-effective performance for all clinicians and aesthetic specialists. LightPod Neo is the only Nd:YAG 1064 nm laser on the market which is capable of delivering the energy fluences required to perform the complete range of aesthetic laser applications (e.g., up to 318j/cm2 used for spider veins and other vascular applications) in this novel MicroPulse-1064™ mode. This allows for clinical efficacy that exceeds industry standards with virtually no treatment discomfort.

Clinical Data

More about LightPod Neo


 

LightPod® Era™
  • MicroPulse-2940™ technology with the inherent benefits of the erbium laser wavelength resulting in minimal downtime combined with efficient tissue ablation.
  • Ideal for treating large pores, spots, wrinkles, scars and cutaneous lesions, age spots, sun damage, solar lentigos and pigmented lesions.
  • The gentle effect of erbium’s 2940 wavelength delivered in short duration pulses allows gentle yet effective treatment of crow’s feet, periorbital wrinkles, smoker’s lines and other perioral wrinkles.
  • Many indications benefit from a “one-two” effect of using Nd: YAG (LightPod Neo) first to remodel collagen and tighten the underlying dermal tissue, followed by erbium resurfacing.
  • The perfect treatment choice for a wide range of classically medical applications such as acne scars, revision of surgical scars, wart removal, milia, nevi, actinic keratoses, seborrheic keratoses, syringomas, carcinomas and other cutaneous lesions.

More about LightPod Era


"From the standpoint of clinical efficacy, the Neo has the ability to perform hair removal in a similar fashion to Nd:YAG 1064nm lasers that employ substantially longer pulse durations. This is true not only in terms of % hair clearance for a given number of treatment sessions but, of particular importance, in terms of long-term results. When combined with the other advantages of the 0.65msec pulse duration – no skin cooling with virtually no treatment pain and the ability to safely treat any skin type – this makes the Neo a unique addition to the field of Nd:YAG lasers from a clinical performance standpoint."
David Friedman, MD

***

"We use LightPod lasers for many applications, but the most rewarding procedure for the patients and the practice is photorejuvenation. Our patients normally experience a natural skin tightening effect that begins following the first treatment. Patient satisfaction is very high.
Aletha Tippett, MD

***

"In our experience, the LightPod Neo benefits patients by providing a wavelength that is safe for darker skin. The use of a pulse duration shorter than the relaxation time of dermal cells allows efficient, long-lasting and virtually pain-free hair removal, which can be critical to patient acceptance of the procedure. I also like the way this laser’s collimated lens allows the operator to work at any distance from the area being treated."
Michael Gold, MD

***

"I use the Neo routinely to treat rosacea, telangiectasias and other vascular lesions. I also use it for hair removal, photorejuvenation and a few medical applications. With this laser I find treatment efficacy and ease of use to be high while the level of pain and discomfort is very low"
Suzanne Rosenberg, DO

***

"I treat many patients with Asian skin. The Neo from Aerolase delivers plenty of power, yet is gentle and safe. In addition to being versatile in terms of the range of skin types and procedures where it can be used, the portability of the Neo appeals to me as I can move it easily among my clinical locations."
Khalil Khatri, MD

***


Back to main page | Back to posts